Forte Biosciences Inc. buy krebskrebs
Start price
04.10.21
/
50%
€2.60
Target price
04.10.22
€5.00
Performance (%)
-58.69%
End price
05.10.22
€1.07
Summary
This prediction ended on 05.10.22 with a price of €1.07. The BUY prediction by krebskrebs for Forte Biosciences Inc. performed very badly with a performance of -58.69%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Forte Biosciences Inc. | 1.527% | 1.527% | -31.443% |
iShares Core DAX® | 0.000% | -2.064% | 13.111% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% |
Comments by krebskrebs for this prediction
In the thread Tocagen diskutieren
Buy mit Kursziel 5,0
In the thread Trading Tocagen
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten